DNASTAR Appoints Pure Health Medical Supplies
News Sep 24, 2015
DNASTAR has appointed Pure Health Medical Supplies Trading Company FZE (Purehealth) as a distributor of its molecular biology software in the Middle East, effective immediately. Purehealth is a company that provides a broad range of products and services to improve human health.
With headquarters in Dubai, Purehealth serves customers and will represent DNASTAR in Bahrain, Egypt, Kuwait, Iraq, Jordan, Oman, Qatar, Saudi Arabia and United Arab Emirates.
Shakoor Malik, the Technical & Marketing Director of Pure health commented, “We are excited to begin this new relationship with DNASTAR. Their 30-year history of meeting the needs of life scientists by offering a broad range of DNA, RNA and protein sequence analysis software and their reputation for providing high quality software and service fit extremely well with our mission and capabilities. We look forward to meeting the needs of commercial, industrial, government and academic customers in the Middle East who want to use the best sequence analysis software available.”
Tom Schwei, Vice President and General Manager of DNASTAR, said, “Purehealth is an outstanding partner for DNASTAR, given their reputation for delivering outstanding products, services and support to their customers and their focus on human health. The timing of this relationship is ideal, given DNASTAR’s growing focus on supporting the needs of molecular biologists and structural biologists in their human health research efforts. We are delighted to work with this strong team to help meet the sequence analysis software needs of life science researchers in the Middle East.”
Getting to Know the Microbes that Drive Climate ChangeNews
A new understanding of the microbes and viruses in the thawing permafrost in Sweden may help scientists better predict the pace of climate change.READ MORE
How Many People Die From TB Every Year?News
Discrepancies between the estimates for global tuberculosis deaths is due to different methodologies and data sources used by each institution. The results highlight the need to improve the modeling approaches in these countries in order to understand the true burden of the disease and design adequate health policies.READ MORE